Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

World News: . []

ANN ARBOR Mich Aug 10 2018 GLOBE NEWSWIRE -- Esperion (NASDAQ: ESPR the Lipid Management Company focused on developing and commercializing complementary convenient cost-effective once-daily oral therapies for the treatment of patients with e...

More news and information about Esperion Therapeutics, Inc.

Published By:

Globe Newswire: 21:30 GMT Friday 10th August 2018

Published: .

Search for other references to "esperion" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us